The number of cases of kidney cancer increases in recent years in Spain.

-in Spain are diagnosed between almost 3,500-4,000 cases per year and, despite the therapeutic efforts, about 20% of them die in the first months 12-14

-new targeted therapies have revolutionized in the last 6 years the treatment of advanced disease, getting delay time of the tumor relapse and in some cases improve overall survival

-the future of the treatment of this disease happens identify and better select patients for each therapy and achieve the best results and tolerability in each case

Madrid, March 2012.- kidney cancer accounts for 3% of the total number of cancer cases diagnosed worldwide. In developed countries, the annual incidence rate is 12 cases per 100,000 males and 5 cases per 100,000 women, treating Genitourinary cancer that leads to higher mortality.

Spain diagnosed between 3,500 and 4,000 cases per year, and despite the therapeutic efforts, about 20% of them die in the first 12-14 months.

In the last two decades, the incidence rate has increased significantly, to an annual rate of 3-4%.

Next celebration of the day of the kidney, on Thursday, March 8, the Spanish group of Oncology Genitourinaria (SOGUG) and GlaxoSmithKline (GSK), wants to sensitize professionals and society in general on this tumor and underline the importance of further clinical research and the multidisciplinary approach of the same.

This type of carcinoma is almost two times more frequent in men than in women, whose majority profile responds to about 60 men – 70 years.

As risk factors associated with your diagnosis, has pointed out obesity, arterial hypertension and tobacco as well as suffering from renal cystic disease, although none of them has a direct relationship with the presence of tumor cells and their growth ”, said Dr. Daniel Castellano, President of SOGUG.

New targeted therapies revolutionize the treatment of kidney cancer

For Dr. Castilian, the use of new targeted therapies anti has revolutionized the treatment of advanced disease, and improve overall survival times of the tumor relapse and in some cases in the last 6 years ”.

Pazopanib (a specific inhibitor of the tirosinaquinasas involved in tumor angiogenesis) stresses between these treatments, given that he has shown very encouraging data of effectiveness and a different toxicity profile, improving the quality of life of patients on other drugs occasionally.

According to the President of SOGUG, the future of the treatment of this disease is to identify and better select patients who benefit from these treatments and customize to achieve the best results and the lowest possible toxicity in each case ”.

Symptoms and diagnosis of renal cancer

The routine use of radiological testing in other pathologies is the reason, surely, that the diagnosis has increased in the last decades of kidney cancer. In this sense, the majority of these tumors are diagnosed when the patient is just symptoms, and a high percentage of cases of form incidental to perform a diagnostic test used routinely for the study of other diseases.

This is in the interests of the patient because that disease is usually detected in the earliest stages and favours a better survival and healing ”, stresses Dr. Spanish.

When there is the presence of symptoms of this tumor, such as pain, hematuria, palpable abdominal mass in flank (classical triad), asthenia, and/or weight loss, usually the disease is now in a more advanced state, implying worse survival.

Spanish Oncology Genitourinary Group (SOGUG)

The Spanish Oncology Genitourinary Group (SOGUG) was created in 1998, with the objective of promoting the development of specific programmes of study and research in the field of Urologic tumors. Since then, has developed research studies phase I-II and phase III. SOGUG collaborates with other groups and societies scientific.

On GSK

GlaxoSmithKline (GSK) is one of the health and pharmaceutical companies based in leading research in the world, is committed to improving the quality of human life by enabling people to do more, feel better and live longer.